5:39 PM
 | 
Sep 03, 2013
 |  BC Extra  |  Financial News

Former Dendreon head, analyst launch biotech hedge fund

Mitchell Gold, former president and CEO of immunotherapy cancer company Dendreon Corp. (NASDAQ:DNDN), and biotech analyst David Miller launched biotech hedge fund Alpine BioVentures. Miller said...

Read the full 111 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >